Black Bird Biotech, Inc. Quarterly Liabilities, Current in USD from Q4 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Black Bird Biotech, Inc. quarterly Liabilities, Current history and growth rate from Q4 2016 to Q3 2023.
  • Black Bird Biotech, Inc. Liabilities, Current for the quarter ending September 30, 2023 was $1.02M, a 23.3% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.02M +$193K +23.3% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $973K +$397K +68.9% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $908K +$618K +213% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $869K +$765K +735% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 $826K +$294K +55.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $576K +$209K +57% Jun 30, 2022 10-Q 2022-08-23
Q1 2022 $290K +$20.5K +7.61% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $104K +$5.45K +5.53% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $532K +$434K +442% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $367K +$317K +636% Jun 30, 2021 10-Q/A 2021-08-24
Q1 2021 $269K +$252K +1432% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $98.5K -$1.04M -91.4% Dec 31, 2020 10-K 2022-04-15
Q3 2020 $98.3K Sep 30, 2020 10-Q 2020-11-23
Q2 2020 $49.9K Jun 30, 2020 10-Q/A 2020-08-20
Q1 2020 $17.6K Mar 31, 2020 10-Q/A 2020-08-11
Q4 2019 $1.14M Dec 31, 2019 10-K 2021-04-15
Q3 2017 $861K Sep 30, 2017 10-Q 2017-11-20
Q2 2017 $843K Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $824K Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $802K Dec 31, 2016 10-Q 2017-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.